These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 30922366

  • 1. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.
    Huang J, Ji EH, Zhao X, Cui L, Misuno K, Guo M, Huang Z, Chen X, Hu S.
    J Exp Clin Cancer Res; 2019 Mar 29; 38(1):138. PubMed ID: 30922366
    [Abstract] [Full Text] [Related]

  • 2. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S, Yang X, Li J, Yang W, Ma H, Zhang Z.
    Mol Cancer; 2019 Mar 11; 18(1):38. PubMed ID: 30857539
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM, Kim SA, Lee DH, Lee JK, Park YL, Lee KH, Chung IJ, Joo YE, Lim SC.
    Oncol Rep; 2017 Jun 11; 37(6):3667-3673. PubMed ID: 28440463
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
    Nakashima T, Yasumatsu R, Kuratomi Y, Masuda M, Kuwano T, Toh S, Umezaki T, Cataltepe S, Silverman GA, Komune S.
    Head Neck; 2006 Jan 11; 28(1):24-30. PubMed ID: 16155915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z, Khan AA, Prasad GB, Khan N, Tiwari RP, Bisen PS.
    Radiother Oncol; 2016 Feb 11; 118(2):359-68. PubMed ID: 26747757
    [Abstract] [Full Text] [Related]

  • 11. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O'Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T.
    Mol Cell Proteomics; 2012 Nov 11; 11(11):1404-15. PubMed ID: 22918226
    [Abstract] [Full Text] [Related]

  • 12. JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.
    Hyakusoku H, Sano D, Takahashi H, Hatano T, Isono Y, Shimada S, Ito Y, Myers JN, Oridate N.
    J Exp Clin Cancer Res; 2016 Jan 12; 35():6. PubMed ID: 26754630
    [Abstract] [Full Text] [Related]

  • 13. Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K/AKT pathway in OLP-associated OSCC.
    Liu Y, Cao P, Xiao L, Tang N, Fei W, Li X.
    J Cell Mol Med; 2024 Jul 12; 28(14):e18556. PubMed ID: 39039706
    [Abstract] [Full Text] [Related]

  • 14. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C, Guo T, Sakai A, Ren S, Fukusumi T, Ando M, Sadat S, Saito Y, Califano JA.
    Cancer; 2020 Feb 15; 126(4):737-748. PubMed ID: 31721164
    [Abstract] [Full Text] [Related]

  • 15. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N, Imanishi Y, Kameyama K, Shimoda M, Tokumaru Y, Sakamoto K, Fujii R, Shigetomi S, Otsuka K, Sato Y, Watanabe Y, Ozawa H, Tomita T, Fujii M, Ogawa K.
    BMC Cancer; 2015 Oct 19; 15():730. PubMed ID: 26483189
    [Abstract] [Full Text] [Related]

  • 16. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.
    Darda L, Hakami F, Morgan R, Murdoch C, Lambert DW, Hunter KD.
    PLoS One; 2015 Oct 19; 10(4):e0122285. PubMed ID: 25860510
    [Abstract] [Full Text] [Related]

  • 17. Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.
    Zhu Z, Xu X, Yu Y, Graham M, Prince ME, Carey TE, Sun D.
    Mol Pharm; 2010 Aug 02; 7(4):1283-90. PubMed ID: 20540527
    [Abstract] [Full Text] [Related]

  • 18. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T, Kurose M, Takano K, Kondoh A, Obata K, Nomura K, Miyata R, Kaneko Y, Konno T, Takahashi S, Hatakeyama T, Kohno T, Himi T, Kojima T.
    Oncotarget; 2016 Jun 07; 7(23):33887-900. PubMed ID: 27036044
    [Abstract] [Full Text] [Related]

  • 19. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A, Ogino T, Bandoh N, Nonaka S, Harabuchi Y.
    Clin Cancer Res; 2005 Apr 15; 11(8):2937-46. PubMed ID: 15837745
    [Abstract] [Full Text] [Related]

  • 20. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
    Bayo P, Jou A, Stenzinger A, Shao C, Gross M, Jensen A, Grabe N, Mende CH, Rados PV, Debus J, Weichert W, Plinkert PK, Lichter P, Freier K, Hess J.
    Mol Oncol; 2015 Oct 15; 9(8):1704-19. PubMed ID: 26040981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.